title: Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.
abstract: The effects of nephropathy risk variants in the apolipoprotein L1 gene (APOL1) on renal histopathology in African Americans with arterionephrosclerosis or putative 'hypertension-associated' nephropathy are unknown. APOL1 genotype-phenotype correlations were performed in a blinded manner from renal biopsies in 196 self-reported African Americans with arterionephrosclerosis on kidney biopsy at a large national nephropathology practice. Subjects had chronic kidney disease without nephrotic syndrome. A discovery analysis compared histopathologic changes in the glomerular and tubulointerstitial compartments in 58 subjects with 2 versus 56 subjects with 0 APOL1 risk variants. Validation was performed in biopsies from 82 additional subjects with 0, 1, and 2 risk variants. Two risk variant versus zero risk variant group genotype associations and subphenotypes were assessed by χ(2) analyses. ANOVA compared means of continuous variables. In discovery analyses, significantly less obsolescent glomerulosclerosis, more (solidified and disappearing) glomerulosclerosis, more thyroidization-type tubular atrophy, and more microcystic tubular dilatation were seen in patients with two versus zero APOL1 risk alleles. Greater degrees of arteriosclerosis were present in those with zero risk alleles. Segmental glomerulosclerosis did not differ significantly between groups. Presence of two of the following discriminatory histopathologic findings from discovery, that is, <50% obsolescent glomerulosclerosis, thyroidization-type tubular atrophy, and microcystic tubular dilatation, was specific for the presence of two APOL1 risk alleles in the validation phase. African Americans with arterionephrosclerosis who possess two APOL1 risk variants more often lack obsolescent glomerulosclerosis and have greater degrees of (solidified and disappearing) glomerulosclerosis, thyroidization-type tubular atrophy, and microcystic tubular dilation than patients with fewer than two risk variants. These findings support involvement of multiple cell types in subnephrotic forms of APOL1-associated nephropathy, particularly renal tubule cells with resultant tubulointerstitial disease.
authors.affiliation: Nephropath, Little Rock, AR, USA.
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Larsen
authors.affiliation: Nephropath, Little Rock, AR, USA.
authors.forename: Marjorie L
authors.initials: ML
authors.lastname: Beggs
authors.affiliation: Nephropath, Little Rock, AR, USA.
authors.forename: Mohammad
authors.initials: M
authors.lastname: Saeed
authors.affiliation: Nephropath, Little Rock, AR, USA.
authors.forename: Josephine M
authors.initials: JM
authors.lastname: Ambruzs
authors.affiliation: Nephropath, Little Rock, AR, USA.
authors.forename: L Nicholas
authors.initials: LN
authors.lastname: Cossey
authors.affiliation: Nephropath, Little Rock, AR, USA.
authors.forename: Nidia C
authors.initials: NC
authors.lastname: Messias
authors.affiliation: Nephropath, Little Rock, AR, USA.
authors.forename: Patrick D
authors.initials: PD
authors.lastname: Walker
authors.affiliation: Internal Medicine-Nephrology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
authors.forename: Barry I
authors.initials: BI
authors.lastname: Freedman
mesh_terms: D001741:Black or African American / Q000235:genetics; D000075944:Apolipoprotein L1; D001053:Apolipoproteins / Q000235:genetics*; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005838:Genotype; D006801:Humans; D008075:Lipoproteins, HDL / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D051436:Renal Insufficiency, Chronic / Q000235:genetics* / Q000473:pathology*
chemical_list: C108666:APOL1 protein, human; D000075944:Apolipoprotein L1; D001053:Apolipoproteins; D008075:Lipoproteins, HDL
references.citation: Lab Invest. 1981 Mar;44(3):280-7
references.pmid: 7464052
references.citation: Science. 2010 Aug 13;329(5993):841-5
references.pmid: 20647424
references.citation: Curr Opin Nephrol Hypertens. 2013 May;22(3):266-72
references.pmid: 23470819
references.citation: Kidney Int. 2002 Jul;62(1):172-80
references.pmid: 12081576
references.citation: Kidney Int. 1999 Feb;55(2):713-23
references.pmid: 9987096
references.citation: Hum Pathol. 1994 Jan;25(1):22-8
references.pmid: 7906246
references.citation: J Am Soc Nephrol. 2011 Nov;22(11):2119-28
references.pmid: 21997392
references.citation: J Am Soc Nephrol. 2013 Sep;24(9):1484-91
references.pmid: 23766536
references.citation: J Am Soc Nephrol. 2011 Nov;22(11):2129-37
references.pmid: 21997394
references.citation: Br J Haematol. 2011 Nov;155(3):386-94
references.pmid: 21910715
references.citation: Hum Genet. 2010 Sep;128(3):345-50
references.pmid: 20635188
references.citation: Atherosclerosis. 2007 Nov;195(1):122-8
references.pmid: 17011566
references.citation: Trans Am Soc Artif Intern Organs. 1977;23:28-33
references.pmid: 910346
references.citation: Kidney Int. 1999 Dec;56(6):2203-13
references.pmid: 10594796
references.citation: J Clin Invest. 2011 Sep;121(9):3367-74
references.pmid: 21881214
references.citation: Arthritis Rheumatol. 2014 Feb;66(2):390-6
references.pmid: 24504811
references.citation: Am J Kidney Dis. 2004 Feb;43(2):368-82
references.pmid: 14750104
references.citation: J Am Soc Nephrol. 2008 Nov;19(11):2047-51
references.pmid: 18923054
references.citation: Kidney Int. 2013 Jan;83(1):114-20
references.pmid: 22832513
references.citation: Am J Kidney Dis. 2002 Apr;39(4):679-88
references.pmid: 11920332
references.citation: Nephrol Dial Transplant. 2011 Nov;26(11):3805-10
references.pmid: 21931123
references.citation: Kidney Int. 2013 Jan;83(1):6-9
references.pmid: 23271482
references.citation: Kidney Int. 1997 Jan;51(1):244-52
references.pmid: 8995739
references.citation: N Engl J Med. 2013 Dec 5;369(23):2183-96
references.pmid: 24206458
references.citation: J Am Soc Nephrol. 2013 Apr;24(5):722-5
references.pmid: 23520206
references.citation: Pathol Res Pract. 1983 Mar;176(2-4):284-96
references.pmid: 6856520